Patent · US Active

Substituted benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses

US8324219B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Shoujun Chen · Bedford, US
Jun Jiang · Shanghai, CN
Junyi Zhang · Lowell, US
Lijun Sun · Harvard, US

Key dates

Filing date	Sep 19, 2008
Grant date	Dec 4, 2012
Priority date	—
Expiry date	Sep 19, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to certain biologically active chemical compounds, such as benzoimidazolyl-pyrazine derivatives of formula (I) or pharmaceutically acceptable salts thereof. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.